Arsenal Biosciences
Source-claim record: this page may be based on an automated extraction. The figure may describe a plan, an aggregate or overlapping coverage and has not necessarily been independently verified as a completed layoff.
Reported figure
?
(majority)
Reported or extracted reason
Strategic shift to in vivo CAR-T technology development
🔮 Oracle Verdict
This layoff has not yet been scored by the Oracle.
Source provenance
https://endpoints.news/arsenal-biosciences-cuts-majority-of-staff-in-move-to-in-…via Google Alerts RSS